Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Kymera Therapeutics (KYMR) Preferred Shares Issued (2019 - 2020)

Kymera Therapeutics (KYMR) has disclosed Preferred Shares Issued for 2 consecutive years, with -$83.4 million as the latest value for Q4 2020.

  • Quarterly Preferred Shares Issued fell 1264.86% to -$83.4 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2020, changed N/A year-over-year, with the annual reading at $4.8 million for FY2020, 77.34% down from the prior year.
  • Preferred Shares Issued for Q4 2020 was -$83.4 million at Kymera Therapeutics, down from -$19000.0 in the prior quarter.
  • The five-year high for Preferred Shares Issued was $88.2 million in Q1 2020, with the low at -$83.4 million in Q4 2020.